John Bradley, M.D.,
is the Director of the Division of Infectious Diseases at Children's Hospital and Health Center, San Diego, California and holds a teaching faculty appointment with the University of California, San Diego.
He is a member of the American Academy of Pediatrics' Committee in Infectious Diseases, and sits on the Antimicrobial Drug Availability Task Force of the Infectious Diseases Society of America. He is currently involved in creating IDSA Collaborative National Guidelines for the Treatment and Prophylaxis of Influenza Infections, and Treatment of Intra-Abdominal Infections.
He served on the FDA's Anti-Infective Drug Advisory Committee for the past 4 years, and has participated in the NIH Collaborative Antiviral Study Group for the past 25 years. He has been involved in anti-infective drug development through the NICHD Pediatric Pharmacology Research Unit Network for the past 10 years. He is a member of the SubBoard for Pediatric Infectious Diseases of the American Board of Pediatrics, and sits on the Council of the Pediatric Infectious Diseases Society.
Dr. Bradley received his Pediatric Infectious Diseases training at Stanford University and has focused his clinical research on therapeutic agents for infectious diseases, with phase I through IV investigations of antibacterial, antiviral and antifungal agents; he has authored or coauthored more than 120 publications. His focus is the treatment of serious infections caused by antibiotic-resistant pathogens, with particular interest in modeling the exposure of antimicrobial agents using pharmacokinetics/pharmacodynamics and Monte Carlo simulation.